This medicine
Drug Images Highlights for meloxicam Meloxicam oral tablet is available as both a generic and brand-name drug
This section describes these warnings and other important safety information about meloxicam
Precautions Talk with your doctor Meloxicam overview Meloxicam (Mobic, Anjeso) is a generic prescription medication
This inflammation can lead to damage, including atherosclerosis, or the buildup of plaque in the artery walls
Chronic exposure to fine particulate matter increased the risk of hospitalization for several cardiovascular conditions in older adults, according to a study published in
Meloxicam, and all NSAIDs, can also increase the risk of a heart attack or stroke, which can result in death
Family history was significant for coronary artery disease in father and brother
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of arthritis (juvenile rheumatoid arthritis, osteoarthritis, and rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain
Meloxicam is a prescription non-steroidal anti-inflammatory drug (NSAID) used for different types of arthritis pain
There is a much greater body of evidence supporting the relative cardiovascular safety of celecoxib when used at the usual doses to treat arthritis than for any of the other selective COX-2 inhibitors or NSAIDs
However, elderly patients are more likely to have serious stomach, heart, or kidney problems, which may require caution and an adjustment in the dose for patients receiving this medicine
Other common NSAIDs are ibuprofen, ketoprofen, and naproxen (all 3 are available both OTC and in prescription strengths)
Geriatric Use Elderly patients, compared to younger patients, are at greater risk for NSAID-associated serious cardiovascular, gastrointestinal, and/or renal adverse reactions
Exceptions For Aleve
Cardiovascular: Monitor blood pressure closely during initiation and throughout course of therapy
red skin lesions, often with a purple center
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam